11ÔÂ28ÈÕ£¬£¬£¬£¬£¬¹ú¼ÒÒ½ÁƱ£ÕϾÖÁªºÏÈËÁ¦×ÊÔ´ºÍÉç»á±£Õϲ¿Õýʽ·¢²¼ÁË¡¶¹ú¼Ò»ù±¾Ò½ÁƱ£ÏÕ¡¢¹¤É˱£ÏÕºÍÉúÓý±£ÏÕҩƷĿ¼(2024Äê)¡·¡£¡£¡£¡£¡£Ôڴ˴θüÐÂÖУ¬£¬£¬£¬£¬È«ÐÂÒ»´ú·Çŵ±´ÌØÀàÒ©Îï--·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒͨ¹ý̸Åгɹ¦ÄÉÈë¹ú¼ÒÒ½±£Ä¿Â¼£¬£¬£¬£¬£¬Õ⽫Ԥʾן߸ÊÓÍÈýõ¥ÑªÖ¢ÖÎÁÆÊг¡½«Ó­À´ÐµľºÕù±ä»¯¡£¡£¡£¡£¡£Ä¿Ç°£¬£¬£¬£¬£¬¹úÄÚÊг¡ÉϽöÓÐÔ­Ñм°ÁªÈðÖÆÒ©Á½¼ÒÆóÒµÉú²úµÄ·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ£¬£¬£¬£¬£¬ÆäÖÐÁªÈðÖÆÒ©Ñз¢Éú²úµÄÊæËÙ´ï®ÊǹúÄÚÊ×·ÂÉÏÊеIJúÆ·¡£¡£¡£¡£¡£

Öйú¸ß¸ÊÓÍÈýõ¥ÑªÖ¢£¨HTG£©µÄ»¼²¡Âʸߴï15%£¬£¬£¬£¬£¬HTG ÊǶ¯ÂöÖàÑùÓ²»¯ÐÔÐÄѪ¹Ü¼²²¡£¡£¡£¡£¡£¨ASCVD£©¼°¼±ÐÔÒÈÏÙÑ×µÄΣÏÕÒòËØÖ®Ò»£¬£¬£¬£¬£¬ÇÒÓ볬ÖØ/·ÊÅÖ¡¢2ÐÍÌÇÄò²¡¡¢·Ç¾Æ¾«ÐÔÖ¬·¾ÐԸβ¡¡¢ÂýÐÔÉöÔಡÓÐÃ÷È·¹ØÁª^[1]¡£¡£¡£¡£¡£

½µ¸ÊÓÍÈýõ¥ÓÃÒ©Ö÷Òª°üÀ¨±´ÌØÀà¡¢ω-3Ö¬·¾ËáÀàºÍÑÌËáÀ࣬£¬£¬£¬£¬¾ÝÃ×ÄÚÍøÊý¾ÝÏÔʾ£¬£¬£¬£¬£¬2024ÄêÉÏ°ëÄê½µ¸ÊÓÍÈýõ¥ÓÃÒ©Ò½ÔºÊг¡ÏúÊÛ¹æÄ£´ïµ½7.4ÒÚ¡£¡£¡£¡£¡£ÓÉÓÚω-3Ö¬·¾ËáÀàÖ÷ҪΪ×ԷѲúÆ·£¬£¬£¬£¬£¬ÑÌËáÀàȱ·¦¼õÉÙÐÄѪ¹Ü·çÏÕµÄÖ¤¾Ý£¬£¬£¬£¬£¬±´ÌØÀà³ÉΪ¹úÄÚÖ÷ÒªÓÃÒ©Ñ¡Ôñ£¬£¬£¬£¬£¬ÆäÖзÇŵ±´ÌØÀàÒ©ÎïÖ¤¾Ý×î³ä×㣬£¬£¬£¬£¬ÁÙ´²Ó¦ÓÃ×î¹ã·º£¬£¬£¬£¬£¬Õ¼±´ÌØÀàÊг¡µÄ90.31%£¬£¬£¬£¬£¬Í¬±ÈÔö³¤10.39%¡£¡£¡£¡£¡£

·Çŵ±´ÌØ×÷ΪǰÌåÒ©Î£¬£¬£¬£¬ ÐèÒªÔÚ¸ÎÔàÖÐõ¥»¯´úл³É·Çŵ±´ÌØËáºó²ÅÄÜ·¢»Ó×÷Ó㬣¬£¬£¬£¬ÓÉÓÚÆäÔÚË®ÖÐÈܽâ¶ÈµÍ£¬£¬£¬£¬£¬ÉúÎïÀûÓöȲ»¸ß£¬£¬£¬£¬£¬ÇÒÐèÒªËæ²Í·þÓ㬣¬£¬£¬£¬¸ø»¼Õß´øÀ´²»±ã^[2]¡£¡£¡£¡£¡£´ËÍ⣬£¬£¬£¬£¬·Çŵ±´ÌØÀàÒ©Îï˵Ã÷ÊéÖеĺڿò¾¯¸æÒ²Ôö¼ÓÁËÓëËûÍ¡ÀàÒ©ÎïÁªÓõݲȫÐÔ¹ËÂÇ^[3]¡£¡£¡£¡£¡£Ëæ×Å·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ£¨É̱êÃû£ºÊæËٴﮣ©µÄÉÏÊУ¬£¬£¬£¬£¬ÓÐЧ½â¾öÁËÒÔÉÏÎÊÌâ¡£¡£¡£¡£¡£

·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ£¨É̱êÃû£ºÊæËٴﮣ©ÒÔÆäÓÅ»¯µÄµ¨¼îÑνṹºÍ»ºÊͼÁÐÍ£¬£¬£¬£¬£¬ÏÔÖøÌáÉýÁËÉúÎïÀûÓöȣ¬£¬£¬£¬£¬Í¬Ê±Æ½»¬ÁËÒ©ÎïŨ¶È·åÖµ£¬£¬£¬£¬£¬ÓÐЧÌá¸ßÁË»¼ÕßµÄÒÀ´ÓÐÔ£¬£¬£¬£¬£¬ÇÒÎÞÐè¸ÎÔà´úлÄܹ»Ö±½ÓÔÚÌåÄÚ·¢»Ó×÷Ó㬣¬£¬£¬£¬´Ó¶ø½µµÍÁ˸ÎÔàµÄ¸ºµ£^[2]¡£¡£¡£¡£¡£

·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ£¨É̱êÃû£ºÊæËٴﮣ©ËµÃ÷ÊéÖÐÃ÷È·Ö¸³ö£¬£¬£¬£¬£¬¿ÉÒÔÓëËûÍ¡ÀàÒ©ÎïÁªºÏʹÓ㬣¬£¬£¬£¬ÇÒÎÞÐèµ÷Õû¼ÁÁ¿£¬£¬£¬£¬£¬¼õÉÙÁË»¼Õ߶ÔÒ©Îïµ÷ÕûµÄµ£ÓÇ£¬£¬£¬£¬£¬ÓÐÀûÓÚÌá¸ßÖÎÁƵÄÒÀ´ÓÐԺʹï±êÂÊ£»£»£»£»£»Ã¿ÈÕ½öÐè·þÓÃÒ»´Î£¬£¬£¬£¬£¬Ã¿´ÎÒ»Á££¨135mg£©£¬£¬£¬£¬£¬²»ÊÜÒûʳӰÏ죬£¬£¬£¬£¬ÎÞÐèËæ²Í·þÓÃ^[4]£¬£¬£¬£¬£¬Îª»¼ÕßÌṩÁËÁé»îµÄÓÃÒ©Ñ¡Ôñ£¬£¬£¬£¬£¬½øÒ»²½ÌáÉýÁËÖÎÁƵıãÀûÐÔ¡£¡£¡£¡£¡£

´ËÍ⣬£¬£¬£¬£¬·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ£¨É̱êÃû£ºÊæËٴﮣ©²ÉÓõij¦ÈÜ»ºÊͼ¼ÊõÓÐÖúÓÚƽÎÈÒ©ÎïÔÚÌåÄÚµÄŨ¶È±ä»¯£¬£¬£¬£¬£¬¼õÉÙ²»Á¼·´Ó¦£¬£¬£¬£¬£¬Ìá¸ßÁËÓÃÒ©µÄ°²È«ÐÔ¡£¡£¡£¡£¡£

×÷Ϊ·Çŵ±´ÌصĻîÐÔ´úл²úÎ£¬£¬£¬£¬·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ£¨É̱êÃû£ºÊæËٴﮣ©ÔÚÁÆЧÎȶ¨ÐÔ¡¢°²È«ÐÔ¡¢±ãÀûÐԵȷ½ÃæÓÅÊÆÃ÷ÏÔ¡£¡£¡£¡£¡£Ëæ×Å·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ½øÈë¹ú¼ÒÒ½±£Ä¿Â¼£¬£¬£¬£¬£¬½«ÓÐÖúÓÚÁÙ´²ÑªÖ¬¹ÜÀí£¬£¬£¬£¬£¬½µµÍ¸ÊÓÍÈýõ¥£¨TG£©Ë®Æ½£¬£¬£¬£¬£¬¼õÉÙÐÄѪ¹Üʼþ·çÏÕ£¬£¬£¬£¬£¬Îª¸ß¸ÊÓÍÈýõ¥ÑªÖ¢ÖÎÁÆÊг¡´øÀ´Ðµķ¢Õ¹»úÓö¡£¡£¡£¡£¡£

²úÆ·×ÉѯÈÈÏߣº400 1833 668

²Î¿¼ÎÄÏ×

[1]   ¸ß¸ÊÓÍÈýõ¥ÑªÖ¢ÁÙ´²¹ÜÀí¶àѧ¿Æר¼Ò¹²Ê¶¹¤×÷×é. ¸ß¸ÊÓÍÈýõ¥ÑªÖ¢¼°ÆäÐÄѪ¹Ü·çÏÕ¹ÜÀíר¼Ò¹²Ê¶[J].ÖйúÑ­»·ÔÓÖ¾,2023,38(6)£º621-630.

[2]   Elisavet Moutzouri ,Anastazia Kei,Moses S elisaf ,Haralampos J Milionis.Management of dyslipidemias with fibrates, alone and in combination with statins: role of delayed-release fenofibric acid.Vascular Health and Risk Management 2010:6 525–539.

[3]   ·Çŵ±´ÌؽºÄÒ˵Ã÷Êé.

[4]   ·Çŵ±´ÌØËᵨ¼î»ºÊͽºÄÒ˵Ã÷Êé.